The VO2 Lounge

Lose 15% Body Weight with Wegovy (Semaglutide): The Benefits and Risks of GLP-1 Agonists


Listen Later

In this episode, we explore weight loss drugs like tirzepatide, semaglutide, and Wegovy. Studies reveal that 80% of participants achieve 15-20% weight loss—but what are the potential downsides? Join us as we dive into the science, benefits, and risks of these ground breaking treatments.

Stay Connected:

  • Join Our WhatsApp Community: https://chat.whatsapp.com/CZ5r5BlqIZx2XusH9ODC3U
  • Instagram: ⁠⁠@thevo2lounge⁠⁠
  • Personalized Coaching Inquiries: ⁠⁠[email protected]⁠⁠
  • Enjoying the Podcast?Explore previous episodes, follow the show, and consider leaving a 5-star review. Your support helps us grow! Share this episode with a friend to expand our community.

    Disclaimer: This podcast is for informational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare provider before beginning any exercise or nutrition program. Your health and safety are your responsibility.

    ...more
    View all episodesView all episodes
    Download on the App Store

    The VO2 LoungeBy Stefan